Company / Free Cash Flow
PURE BIOSCIENCE, INC. Free Cash Flow History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$3.3M
FY2023
5-year range
-$3.3M / -$1.7M
FY2019-FY2023
Trend
-32.5%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has declined for 3 consecutive years, from $611,000 in FY2020 to -$3M in FY2023.
Based on SEC 10-K filings.
-$3M in FY2023.
Declined from -$2M to -$3M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- PURE BIOSCIENCE, INC.'s free cash flow has declined for 3 consecutive years.
- In FY2023, free cash flow decreased 32.5% year-over-year.
- Peak free cash flow was recorded in FY2020.
- Lowest free cash flow in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -116.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -$3.3M | -32.5% |
| FY2022 | -$2.5M | -48.0% |
| FY2021 | -$1.7M | -376.3% |
| FY2020 | $611.0K | +120.4% |
| FY2019 | -$3.0M | +23.3% |
| FY2018 | -$3.9M | +18.1% |
| FY2017 | -$4.8M | +11.4% |
| FY2016 | -$5.4M | +12.4% |
As of FY2023 · SEC Form 10-K · Last checked Jun 29, 2026